trial

Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients

NCTId NCT00295139
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 293 (actual)
Sponsored by University of Maryland, Baltimore County
Primary completion 2010-03
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
293 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2005-01
Primary completion
2010-03
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
Behavioral Treatment for Substance Abuse in SPMI (BTSAS)Supportive Treatment in Addiction Recovery (STAR)Critical Time Intervention (CTI)

Sponsors

University of Maryland, Baltimore CountyLead Sponsor
National Institute on Drug Abuse (NIDA)Collaborator

Investigators

1
Alan S. Bellack, Ph.D.Principal Investigator

Sites

4 total
Baltimore, United StatesBaltimore, United StatesBaltimore, United StatesCatonsville, United States

Facts & assertions

4 sourced
Enrollment
293
Phase
NA
Primary Completion Date
2010-03
Status
COMPLETED
relationships
The graph out of here
drug
Behavioral Treatment for Substance Abuse in SPMI (BTSAS)
drug
Supportive Treatment in Addiction Recovery (STAR)
drug
Critical Time Intervention (CTI)
drug
lead_sponsor
University of Maryland, Baltimore County
company
collaborator
National Institute on Drug Abuse (NIDA)
company
indication
Schizophrenia
indication
Substance Dependence
indication
Substance-Related Disorders
indication
investigator
Alan S. Bellack, Ph.D.
person